[Double blind study of tiapride in neoplasia-related pains (author's transl)].

The antalgic effects of tiapride used by intravenous way have been evaluated in a randomized study on 30 patients with neoplasia-related pains. We noticed a partial or a complete positive response in 60 % of the cases when tiapride is given at a dose of 300 mg/day. The average efficient period was about four hours. Tolerance was good.